Loading...

The National Cervical Cancer Elimination Action Plan 2025 - 2030

HPV Vaccination

HPV vaccination coverage among eligible girls is increased to at least 90%.

Operational Objectives
  • Expand equitable, timely, and integrated HPV vaccine delivery
  • Strengthen HPV vaccination workforce capacity
  • Strengthen HPV vaccination data systems
  • Strengthen HPV vaccine supply chains
  • Secure sustainable HPV vaccine financing
  • Promote political leadership and multisectoral coordination to support HPV vaccination.
  • Promote behavior change communication for HPV vaccine uptake.

HPV vaccination coverage among eligible girls is increased to at least 90%.

Screening and Pre-Cancer Treatment

Operational Objectives
  • Ensure facility readiness for screening and precancer treatment.
  • Ensure quality assurance in cervical cancer screening.
  • Strengthen health worker cervical cancer screening.
  • Increase community awareness and screening demand
  • Improve data use for decision-making
  • Prioritize financing for cervical cancer screening and treatment
  • Strengthen leadership and governance for the cervical cancer screening program
  • Ensure provision of quality screening and precancer treatment services.

At least 70% of women 30-49 years are screened using HPV testing; and at least 90% of those with precancer receive treatment

90%

of Girls Fully Vaccinated Against HIV by 15 Years

70%

of Women are Screened with High Performance Tests by 35 and 45 Years

90%

of Women Identified Receive Treatment for Pre-Concievable

Diagnosis, Treatment, Palliative & Survivorship Care

Operational Objectives
  • Strengthen infrastructure for cervical cancer diagnosis and treatment.
  • Expand skilled multidisciplinary oncology workforce.
  • Ensure availability of cervical cancer diagnosis and treatment technologies/supplies
  • Provide comprehensive financial coverage for cervical cancer diagnosis and treatment
  • Strengthen data systems for cervical cancer diagnosis and treatment.
  • Strengthen leadership and governance for diagnosis and treatment.

At least 90% of women with invasive cervical cancer receive comprehensive treatment, palliative and survivorship care.